Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


suck pdf from google scholar
PDF vom PMID32336069 :   free

suck abstract from ncbi

Nephropedia Template TP Text

Twit Text FOAVip

Twit Text #

English Wikipedia

  • What should a cardiologist know about coronavirus disease 2019? #MMPMID32336069
  • Slawinski G; Lewicka E
  • Kardiol Pol 2020[Apr]; 78 (4): 278-283 PMID32336069show ga
  • Severe acute respiratory syndrome coronavirus 2 (SARSCoV2) is the cause of coronavirus disease 2019 (COVID19). The most common symptoms of COVID19 are: fever (81.8%-100%), cough (46.3%-86.2%), myalgia and fatigue (11%-50%), expectoration (4.4%-72%), and dyspnea (18.6%-59%). The most common laboratory abnormalities in COVID19 include decreased lymphocyte count (35%-82.1%), thrombocytopenia (17%-36.2%), elevated serum Creactive protein (60.7%-93%), lactate dehydrogenase (41%-76%), and Ddimer concentrations (36%-46.4%). Among comorbidities in patients with COVID19, cardiovascular disease is most commonly found. In addition, patients with concomitant cardiovascular diseases have worse prognosis and more often require admission to the intensive care unit (ICU), compared with patients without such comorbidities. It is estimated that about 20% of patients with COVID19 develop cardiac injury. Cardiac injury is more prevalent among patients with COVID19 who require ICU care. In a group of critically ill patients, 27.5% had an elevated Nterminal pro-Btype natriuretic peptide concentration, and increased cardiac troponin level was found in 10% of patients. One of the lifethreatening cardiac manifestations is coronavirus fulminant myocarditis, which may also occur without accompanying symptoms of pulmonary involvement. Early recognition and treatment is crucial in these cases. So far, data on the incidence of arrhythmias in patients with COVID19 are limited. Coronavirus disease 2019 impacts patients with cardiovascular comorbidities and affects daily practice of cardiologists. Thus, it is important to know typical COVID19 symptoms, possible clinical manifestations, complications, and recommended treatment.
  • |Angiotensin Receptor Antagonists/adverse effects/therapeutic use[MESH]
  • |Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use[MESH]
  • |Antiviral Agents/adverse effects/therapeutic use[MESH]
  • |Cardiology[MESH]
  • |Cardiovascular Diseases/drug therapy/*epidemiology/etiology[MESH]
  • |Comorbidity[MESH]
  • |Coronavirus Infections/*diagnosis/drug therapy/*epidemiology/metabolism[MESH]
  • |Cost of Illness[MESH]
  • |Critical Care[MESH]
  • |Diabetes Mellitus/epidemiology[MESH]
  • |Humans[MESH]
  • |Pandemics[MESH]
  • |Peptidyl-Dipeptidase A/metabolism[MESH]
  • |Pneumonia, Viral/*diagnosis/drug therapy/*epidemiology/metabolism[MESH]
  • |Professional Practice[MESH]
  • |Prognosis[MESH]
  • |Tomography, X-Ray Computed[MESH]

  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    278 4.78 2020